Skip to main content
SpringerLink
Log in

Overexpression of GOLPH3 protein is associated with worse prognosis in patients with epithelial ovarian cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Golgi phosphoprotein 3 (GOLPH3) has important roles in the pathogenesis of cancer, and overexpression of GOLPH3 has been found in several kinds of cancers. However, the relationship between GOLPH3 overexpression and prognosis in patients with epithelial ovarian cancer remains unknown. This study aimed to investigate the relationship between GOLPH3 overexpression and overall survival in patients with epithelial ovarian cancer. The expression of GOLPH3 protein in tumor tissue was evaluated using immunohistochemistry. Seventy-five patients with epithelial ovarian cancer with the data of GOLPH3 expression and follow-up were included. GOLPH3 overexpression was significantly associated with advanced stage, histology, high grade, and lymph node metastases (P < 0.05). Kaplan-Meier analysis showed that patients with GOLPH3 overexpression had significantly poorer overall survival than those with low expression of GOLPH3 (log-rank P < 0.001). In the multivariate Cox proportional hazards analysis, GOLPH3 overexpression was independently associated with poorer overall survival (hazard ratio [HR] = 3.60; 95 % confidence interval (CI0 1.14–11.33, P = 0.03). Therefore, overexpression of GOLPH3 protein is closely related to poorer prognosis in patients with epithelial ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cho KR, Shih IM. Ovarian cancer. Annu Rev Pathol. 2009;4(1):287–313.

    Article  CAS  Google Scholar 

  2. Wang Y, Wang D, Ren M. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis. Tumor Biol. 2014;35(1):33–8.

    Article  Google Scholar 

  3. Kandalaft LE, Motz GT, Duraiswamy J, Coukos G. Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance. Cancer Metastasis Rev. 2011;30(1):141–51.

    Article  CAS  Google Scholar 

  4. Wu XJ, Yuan P, Li ZY, Bu ZD, Zhang LH, Wu AW, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patietns with ovarian metastasis and peritoneal dissemination. Tumor Biol. 2013;34(1):463–9.

    Article  CAS  Google Scholar 

  5. Clarke-Pearson DL. Clinical practice. Screening for ovarian cancer. N Engl J Med. 2009;361(2):170–7.

    Article  CAS  Google Scholar 

  6. Cooke SL, Brenton JD. Evolution of platinum resistance in high-grade serous ovarian cancer. Lancet Oncol. 2011;12(12):1169–74.

    Article  CAS  Google Scholar 

  7. Kulasingam V, Pavlou MP, Diamandis EP. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer. 2010;10(5):371–8.

    Article  CAS  Google Scholar 

  8. Karam AK, Karlan BY. Ovarian cancer: the duplicity of ca125 measurement. Nat Rev Clin Oncol. 2010;7(6):335–9.

    Article  CAS  Google Scholar 

  9. Chen MB, Wu XY, Yu R, Li C, Wang LQ, Shen W, et al. P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer. PLoS ONE. 2012;7(9):e45388.

    Article  CAS  Google Scholar 

  10. Kemal Y, Demirag G, Ekiz K, Yucel I. Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer. J Obstet Gynaecol. 2014;15(1):1–4.

    Google Scholar 

  11. Caceres-Gorriti KY, Carmona E, Barres V, Rahimi K, Letouneau IJ, Tonin PN, et al. RAN necleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer. PLoS ONE. 2014;9(3):e91000.

    Article  Google Scholar 

  12. Chen WT, Gao X, Han XD, Zheng H, Guo L, Lu RQ. HE4 as a serum biomarker for ROMA prediction and prodiction and prognosis of epithelial ovarian cancer. Asian Pac J Cancer Prev. 2014;15(1):101–5.

    Article  Google Scholar 

  13. Scott KL, Chin L. Signaling from the golgi: mechanisms and models for golgi phosphoprotein 3-mediated oncogenesis. Clin Cancer Res. 2010;16(8):2229–34.

    Article  CAS  Google Scholar 

  14. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, et al. Golph3 modulates mtor signalling and rapamycin sensitivity in cancer. Nature. 2009;459(7250):1085–90.

    Article  CAS  Google Scholar 

  15. Dippold HC, Ng MM, Farber-Katz SE, Lee SK, Kerr ML, Peterman MC, et al. Golph3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the golgi to promote budding. Cell. 2009;139(2):337–51.

    Article  CAS  Google Scholar 

  16. Farber-Katz SE, Dippold HC, Buschman MD, Peterman MC, Xing M, Noakes CJ, et al. DNA damage triggers golgi dispersal via DNA-PK and GOLPH3. Cell. 2014;156(3):413–27.

    Article  CAS  Google Scholar 

  17. Xue Y, Wu G, Liao Y, Xiao G, Ma X, Zou X, et al. Golph3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma. Br J Cancer. 2014;110(9):2250–60.

    Article  CAS  Google Scholar 

  18. Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, et al. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the foxo1 transcription factor. Clin Cancer Res. 2012;18(15):4059–69.

    Article  CAS  Google Scholar 

  19. Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, et al. Increased expression of golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol. 2012;7(1):127.

    Article  CAS  Google Scholar 

  20. Zhou J, Xu T, Qin R, Yan Y, Chen C, Chen Y, et al. Overexpression of golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis. J Neurooncol. 2012;110(2):195–203.

    Article  CAS  Google Scholar 

  21. Hu BS, Hu H, Zhu CY, Gu YL, Li JP. Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer. Tumour Biol. 2013;34(1):515–20.

    Article  Google Scholar 

  22. Ma Y, Ren Y, Zhang X, Lin L, Liu Y, Rong F, et al. High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma. Virchows Arch. 2014;464(4):443–52.

    Article  CAS  Google Scholar 

  23. Farber-Katz SE, Dippold HC, Buschman MD, Peterman MC, Xing M, Noakes CJ, et al. DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3. Cell. 2014;156(3):413–27.

    Article  CAS  Google Scholar 

  24. Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, et al. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med. 2012;10(1):168.

    Article  Google Scholar 

  25. Cao J, Cai J, Huang D, Han Q, Chen Y, Yang Q, et al. Mir-335 represents an independent prognostic marker in epithelial ovarian cancer. Am J Clin Pathol. 2014;141(3):437–42.

    Article  Google Scholar 

  26. Liu T, Gao H, Chen X, Lou G, Gu L, Yang M, et al. TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer. Br J Cancer. 2013;109(6):1685–92.

    Article  CAS  Google Scholar 

  27. Lee JY, Myung SK, Song YS. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies. Gynecol Oncol. 2013;129(3):613–9.

    Article  CAS  Google Scholar 

  28. Taft MH, Behrmann E, Munske-Weidemann LC, Thiel C, Raunser S, Manstein DJ. Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3. J Biol Chem. 2013;288(42):30029–41.

    Article  CAS  Google Scholar 

  29. Chang WL, Chang CW, Chang YY, Sung HH, Lin MD, Chang SC, et al. The Drosophila GOLPH3 homolog regulates the biosynthesis of heparan sulfate proteoglycans by modulating the retrograde trafficking of exostosins. Development. 2013;140(13):2798–807.

    Article  Google Scholar 

  30. Sechi S, Colotti G, Belloni G, Mattei V, Frappaolo A, Raffa GD, et al. GOLPH3 is essential for contractile ring formation and Rab11 localization to the cleavage site during cytokinesis in Drosophila melanogaster. PLoS Genet. 2014;10(5):e1004305.

    Article  Google Scholar 

  31. Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, Besenbacher S, et al. Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet. 2011;43(11):1104–7.

    Article  CAS  Google Scholar 

  32. Glienke W, Maute L, Wicht J, Bergmann L. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines. Tumor Biol. 2012;33(3):757–65.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

None.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, Shandong Qianfoshan Hospital, Shandong University, Jinan, Shandong, 250014, People’s Republic of China

    Yingchun Ma, Binghui Sun, Hongtao Lv & Fengnian Rong

  2. Department of Obstetrics and Gynecology, Liaocheng People’s Hospital, Liaocheng, Shandong, 252000, People’s Republic of China

    Yingchun Ma & Xiuxia Wang

  3. Department of Gynecology and Obstetrics, Jinan Shizhong People’s Hospital, Shandong, 250002, People’s Republic of China

    Yuanhong Wu

  4. Department of Gynecology and Obstetrics, Jinan Maternity and Child Healthcare Hospital, Shandong, 250001, People’s Republic of China

    Xiaoxia Zheng

Authors
  1. Yingchun Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiuxia Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuanhong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Binghui Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hongtao Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fengnian Rong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaoxia Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yingchun Ma, Fengnian Rong or Xiaoxia Zheng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Y., Wang, X., Wu, Y. et al. Overexpression of GOLPH3 protein is associated with worse prognosis in patients with epithelial ovarian cancer. Tumor Biol. 35, 11845–11849 (2014). https://doi.org/10.1007/s13277-014-2411-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2411-1

Keywords

Search

Navigation